Logo image of SINT

SINTX TECHNOLOGIES INC (SINT) Stock Fundamental Analysis

NASDAQ:SINT - Nasdaq - US8293927039 - Common Stock - Currency: USD

5.31  +0.51 (+10.62%)

After market: 5.4525 +0.14 (+2.68%)

Fundamental Rating

3

Taking everything into account, SINT scores 3 out of 10 in our fundamental rating. SINT was compared to 190 industry peers in the Health Care Equipment & Supplies industry. The financial health of SINT is average, but there are quite some concerns on its profitability. SINT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SINT has reported negative net income.
SINT had a negative operating cash flow in the past year.
In the past 5 years SINT always reported negative net income.
In the past 5 years SINT always reported negative operating cash flow.
SINT Yearly Net Income VS EBIT VS OCF VS FCFSINT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -103.07%, SINT is not doing good in the industry: 84.04% of the companies in the same industry are doing better.
SINT has a Return On Equity of -208.74%. This is in the lower half of the industry: SINT underperforms 76.60% of its industry peers.
Industry RankSector Rank
ROA -103.07%
ROE -208.74%
ROIC N/A
ROA(3y)-67.03%
ROA(5y)-67.52%
ROE(3y)-145.89%
ROE(5y)-129.23%
ROIC(3y)N/A
ROIC(5y)N/A
SINT Yearly ROA, ROE, ROICSINT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150 -200 -250

1.3 Margins

Looking at the Gross Margin, with a value of 66.06%, SINT is in the better half of the industry, outperforming 70.21% of the companies in the same industry.
In the last couple of years the Gross Margin of SINT has grown nicely.
The Profit Margin and Operating Margin are not available for SINT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y51.86%
GM growth 5Y11.31%
SINT Yearly Profit, Operating, Gross MarginsSINT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5K -10K -15K -20K

6

2. Health

2.1 Basic Checks

SINT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SINT has been increased compared to 1 year ago.
SINT has more shares outstanding than it did 5 years ago.
SINT has a better debt/assets ratio than last year.
SINT Yearly Shares OutstandingSINT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5K 10K 15K 20K 25K
SINT Yearly Total Debt VS Total AssetsSINT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -36.24, we must say that SINT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SINT (-36.24) is worse than 89.36% of its industry peers.
There is no outstanding debt for SINT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -36.24
ROIC/WACCN/A
WACC9.01%
SINT Yearly LT Debt VS Equity VS FCFSINT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 3.04 indicates that SINT has no problem at all paying its short term obligations.
With a Current ratio value of 3.04, SINT perfoms like the industry average, outperforming 54.26% of the companies in the same industry.
SINT has a Quick Ratio of 2.82. This indicates that SINT is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.82, SINT is doing good in the industry, outperforming 61.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 2.82
SINT Yearly Current Assets VS Current LiabilitesSINT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

5

3. Growth

3.1 Past

SINT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.77%, which is quite impressive.
The Revenue has grown by 30.40% in the past year. This is a very strong growth!
SINT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.24% yearly.
EPS 1Y (TTM)98.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.1%
Revenue 1Y (TTM)30.4%
Revenue growth 3Y64.14%
Revenue growth 5Y94.24%
Sales Q2Q%17.85%

3.2 Future

The Earnings Per Share is expected to grow by 41.22% on average over the next years. This is a very strong growth
Based on estimates for the next years, SINT will show a decrease in Revenue. The Revenue will decrease by -3.15% on average per year.
EPS Next Y97.87%
EPS Next 2Y41.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year23.6%
Revenue Next 2Y-3.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SINT Yearly Revenue VS EstimatesSINT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
SINT Yearly EPS VS EstimatesSINT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M -250M

1

4. Valuation

4.1 Price/Earnings Ratio

SINT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SINT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SINT Price Earnings VS Forward Price EarningsSINT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SINT Per share dataSINT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80

4.3 Compensation for Growth

A more expensive valuation may be justified as SINT's earnings are expected to grow with 41.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.22%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SINT!.
Industry RankSector Rank
Dividend Yield N/A

SINTX TECHNOLOGIES INC

NASDAQ:SINT (2/21/2025, 8:00:02 PM)

After market: 5.4525 +0.14 (+2.68%)

5.31

+0.51 (+10.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)05-12 2025-05-12
Inst Owners1.89%
Inst Owner Change1211.54%
Ins Owners0%
Ins Owner Change0%
Market Cap7.12M
Analysts43.33
Price Target71.4 (1244.63%)
Short Float %2.62%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)87.81%
Min EPS beat(2)75.98%
Max EPS beat(2)99.64%
EPS beat(4)4
Avg EPS beat(4)63.65%
Min EPS beat(4)29.97%
Max EPS beat(4)99.64%
EPS beat(8)4
Avg EPS beat(8)-37.2%
EPS beat(12)7
Avg EPS beat(12)-19.59%
EPS beat(16)10
Avg EPS beat(16)-11.77%
Revenue beat(2)2
Avg Revenue beat(2)16.19%
Min Revenue beat(2)11.9%
Max Revenue beat(2)20.48%
Revenue beat(4)3
Avg Revenue beat(4)6.85%
Min Revenue beat(4)-15.39%
Max Revenue beat(4)20.48%
Revenue beat(8)5
Avg Revenue beat(8)5.83%
Revenue beat(12)7
Avg Revenue beat(12)10.06%
Revenue beat(16)9
Avg Revenue beat(16)2.47%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)49.23%
EPS NQ rev (3m)-233.94%
EPS NY rev (1m)18.42%
EPS NY rev (3m)20.76%
Revenue NQ rev (1m)-6.67%
Revenue NQ rev (3m)-35.62%
Revenue NY rev (1m)2.44%
Revenue NY rev (3m)6.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.19
P/FCF N/A
P/OCF N/A
P/B 1.27
P/tB 1.28
EV/EBITDA N/A
EPS(TTM)-93.14
EYN/A
EPS(NY)-4.17
Fwd EYN/A
FCF(TTM)-8.41
FCFYN/A
OCF(TTM)-7.94
OCFYN/A
SpS2.42
BVpS4.16
TBVpS4.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -103.07%
ROE -208.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.06%
FCFM N/A
ROA(3y)-67.03%
ROA(5y)-67.52%
ROE(3y)-145.89%
ROE(5y)-129.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y51.86%
GM growth 5Y11.31%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.17%
Cap/Sales 19.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.04
Quick Ratio 2.82
Altman-Z -36.24
F-Score4
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)813.08%
Cap/Depr(5y)602.07%
Cap/Sales(3y)242.39%
Cap/Sales(5y)161.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.1%
EPS Next Y97.87%
EPS Next 2Y41.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.4%
Revenue growth 3Y64.14%
Revenue growth 5Y94.24%
Sales Q2Q%17.85%
Revenue Next Year23.6%
Revenue Next 2Y-3.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.77%
OCF growth 3YN/A
OCF growth 5YN/A